# Vegestar

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vegestar

- Industry: Food
- Headquarters: Incheon, South Korea
- Website: www.vegestar.co.kr
- Total disclosed funding: $2.6M
- Latest round: Series B (Dec 16, 2022)
- Investors on record: 7

## About

Based in South Korea and founded in 2020, Vegestar operates as a fresh food platform that produces food products for domestic food companies. In December 2022, Vegestar raised Series B funding from Samho Green Investment, Medici Investments, and Evergreen Investment Partners, with participation from NAU IB Capital and Enlight Ventures. The Series B funding was part of KRW 15 billion in equity funding. As of 2023, Peeter Tava is operating as chief executive officer of Vegestar. 

Vegestar provides pre-processed agricultural products that include salads, meal kits, and many more. In addition, the firm washes and trims soiled agricultural products and partners with various agriculture companies, providing support with purchasing, processing, and manufacturing. As of 2023, the company’s client base includes Fresheasy, Salady, Subway, Tasty, GS Shop, Welstory, Coupang, and Ashley. 

The company generated sales revenue of KRW 30 billion in 2021, and the sales percentage of products were agricultural products pre-processing (42%), salads (28%, meal kits (22%), and HMR (8%).

## Funding rounds

- Series B, Dec 16, 2022 — Samho Green Investment, NAU IB Capital, Enlight Ventures, Evergreen Investment Partners, Medici Investments
- Series A, Apr 5, 2021, $2.6M — NH Bank, NAU IB Capital, Dong Hoon Investment

## Investors

- NH Bank — Series A
- NAU IB Capital (https://capitalatlas.ai/funds/nau-ib-capital) — Series A, Series B
- Dong Hoon Investment (https://capitalatlas.ai/funds/dong-hoon-investment) — Series A
- Samho Green Investment (https://capitalatlas.ai/funds/samho-green-investment) — Series B
- Enlight Ventures (https://capitalatlas.ai/funds/enlight-ventures) — Series B
- Evergreen Investment Partners (https://capitalatlas.ai/funds/evergreen-investment-partners) — Series B
- Medici Investments — Series B